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Lymphoblastoid lines, derived by transforming pe-
ripheral blood lymphocytes with Epstein-Barr virus, and 
skin fibroblast lines were established from two patients 
with tuberous sclerosis. The number of viable lympho-
blastoid cells was determined by their ability to exclude 
the vital dye trypan blue after their irradiation with x-
rays or 254 nm ultraviolet light. The growth of fibro-
blasts was determined by their ability to form colonies 
after treatment with the radiomimetic, DNA-damaging 
chemical N-methyl-N'-nitro-N-nitrosoguanidine. The tu-
berous sclerosis lymphoblastoid lines were hypersensi-
tive to x-rays but had normal sensitivity to the ultravi-
olet radiation. The tuberous sclerosis fibroblast lines 
were hypersensitive to the N-methyl-N'-nitro-N-nitro-
soguanidine. The hypersensitivity of tuberous sclerosis 
cells to x-rays and to N-methyl-N'-nitro-N-nitrosoguan-
idine is believed to reflect defective repair of DNA dam-
aged by these agents and may provide the basis for in 
vitro, including prenatal, diagnostic tests for tuberous 
sclerosis. 
It has been postulated that certain hereditary neurocuta-
neous disorders might have certain pathogenetic mechanisms 
in common [1,2). This postulate has been supported by discov-
eries that xeroderma pigmentosum (XP) [3-5], Cockayne syn-
drome (CS) [5-7], and ataxia telangiectasia (AT) [ 4,5], all of 
which are classified as neurocutaneous disorders [1], h ave in-
herited defects in mechanisms normally involved in the repair 
of damaged DNA. These inherited defects are thought to ac-
count for the hypersensitivity exhibited by these patients' cells 
to physical and chemical DNA-damaging agents. Thus, cultmed 
cells from patients with XP [3-5,8] or CS [5,6] are hypersensi-
tive to ultraviolet (UV) radiation and to UV -mimetic chemicals, 
while AT [ 4,5,8] cells are hypersensitive to ionizing radiation 
a nd to radiomimetic chemicals. 
It has recently been briefly reported that there is hypersen-
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Abbreviations: ' 
XP: xeroderma pigmentosum 
CS: Cockayne syndrome 
AT: ataxia telangiectasia 
UV: ultraviolet 
TS: tuberous sclerosis 
MNNG: N-methyl-N' -nitro-N-nitrosoguanidine 
AT het: ataxia telangiectasia heterozygote 
CFA: colony-forming ability 
sitivity to ionizing radiation [ 4,9,10] in cells from some patients 
with tuberous sclerosis (TS) [11], another neurocutaneous dis-
order [1,2,11]. We have studied in vitro lymphoblastoid and 
fibroblast lines derived from 2 TS patients and now report that 
both patients' lines are abnormally sensitive to x-rays and to 
the radiomimetic chemical N-methyl-N' -nitro-N-nitrosoguani-
dine (MNNG). Preliminary results of our findings h ave been 
published [10,12]. 
MATERIALS AND METHODS 
Post-x-Ray a.n.d Post- UV Survival Experiments with 
Lymphobla.stoid Lines 
Lymphoblastoid lines: All the lymphoblastoid lines were derived by 
transforming peripheral blood lymphocytes with Epstein-Barr virus. 
XP line XP17BE-L1 was established in ouT laboratory but is now 
available as line GM 2253 from The Human Genetic Mu tant Cell 
Repository, Copewood and Davis Streets, Camden, New Jersey. All 
other lines studied were established at the repository and are as follows: 
apparently normal lines GM 536, 606,892,923, 1056, and 1310; AT li nes 
GM 717, 1526, a nd 3189; AT heterozygote (AT het) lines GM 3187 and 
3188, from the parents of GM 3189; XP lines GM 2253 (XP17BE) [13] 
and GM 2345 (XP20S) [14], both from patients with neurological 
abnormalities of XP; CS line GM 1712 (CS2BE) [15]; T S lines GM 1636 
and 1638. Line GM 1636 was derived from a 17-yr-old man, designated 
TS1BE, • who had severe mental retardation, seizures since 4 mo of 
age, adenoma sebaceum, and shagreen patches. Line GM 1638 was 
derived from a 20-yr-old woman, designated TS2BE, who had severe 
mental retardation, grand mal seizures since childhood, adenoma e-
baceum, ash-leaf hypomelanotic macules, shagreen patches, and per-
iungual fibromas. 
Cultw·e and irradiation. techniques: The lymphoblasto id lines were 
cultured and irradiated as described previously [16]. The lines were 
maintained at concentrations between 2 x 10'' and 3 x 10H cells/ml at 
37°C in a humidified atmosphere of 5% C0~:95% a ir in RPM! medium 
1640 (Gibco) containing 20% fetal bovine serum (Gibco). The growth 
rates of nonirradiated normal and patient lines were not significantly 
different. An hour before irradiat ion l ml of the cell suspension was 
mixed with 1 ml of a trypan blue solution (0.4% in normal saline) 
(GIBCO, Cat. No. 630-5250), and the trypan blue-excluding cells (i.e., 
"viable" cells) were counted in a hemocytometer. The culture medium 
was then centrifuged at 600 g for 10 min, and the cells were resuspended 
to a final concentration of 3 x 10° viable cells/ml of fresh cultm e 
medium for x-ray experiments or to 4 x 106 cells/ml of Hanks' balanced 
salt solution (without phenol red) for UV experiments. 
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For the x-ray experiments cells were irradiated with a i.r as the gas 
phase by a 235 kVp double-headed x-ray machine through 0.25 mm 
copper and 0.55 mm aluminum filters at 126 rads/min. The cells were 
then cultured, and their viability was determined by the trypan blue 
exclusion method. In preliminary experiments the post-x-ray viability 
of 2 normal lines was determined on each of the firs t 4 days after 
irradiation. Their post-x-ray viability ratios fell successively during the 
fLrst 3 posti.rradiation days. Since their ratios on the fomth day were 
• In partial accordance wit h an international effort to standardize 
nomenclature of cell lines from patients with heredi tary diseases, om 
designation ofTS1BE will signify both the patient and cell lines derived 
from the patient: TS, tuberous sclerosis; 1, fu·st patient of our T 
patient se1 ies; BE, for Bethesda, Maryland, where the patient was 
examined and characterized clinically. 
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t h e sam e as on the third day and since the nonirradiated lines were all 
still in log-phase exponential growth on the third but not on the fourth 
p ostirradiation day, all viability ratios were determined on the third 
d ay after irradiation wi th 100 rads. The total number of viable cells in 
t h e normal and pat ien t lines continued to increase during these 3 
p ostirradiation days. 
F or t he UV experiments the cells were irradiated in the Hanks' 
s olut ion with 6.0 J / m2 from a germicidal lamp (General E lectric lamp 
N o. G 15T8) . Immediately a fter the time of irradiation, each volu me of 
t h e cell suspension was diluted wit h 7 volumes of fresh medium, and 
t h e cells were incubated for 3 days after which the viable cells were 
determined by the trypan blue exclusion method. 
All the resul ts with x-rays reported in this paper were obtained under 
conditions of maximum sensitivity of the assay as existed in a previous 
study with Huntington disease cells [16]. After the cw-rent work was 
completed, the assay abruptly underwent 2 unexplained decreases in 
discrimina tive abili ty: the period of maximum discrimination was fo l-
lowed by a period of reduced discrimination, and, currently, only AT 
lines, the most radiosensit ive human cells known, can be distinguished 
from the normal lines whose viability ratios have not changed. While 
t h e cause of the loss of sensitivity is not known, it appears to have 
arisen soon after a new batch of feta l bovine serum was ut i.l ized. 
Attempts to regain the maximum sensit ivity are in progress. The 
h ypersensit ivity to x-rays found during the period of maximum sensi-
tivity suggested that the TS patients' cells would be hypersensitive to 
radiomimetic chemicals, and we therefore conducted fibroblast-MNNG 
studies (see infra ). 
S tatistics: A lymphoblastoid line's postirradiation via bi.li ty ratio was 
calcula ted by dividing the concentra tion of viable cells in an irradiated 
c ult UJ·e on the third postirradiation day by the concentration of viable 
cells in an unirradiated culture of the same line on the same day. For 
the experiments represented in Table I, the statistical analysis was 
per formed using analysis of variance methods [17], and 2-sided ?-
values are reported. 
F ibroblast-MNNG Survival Experiments 
Fibroblast lines: Fibroblast lines with a "CRL" prefix were obtained 
from the Am erican T ype Culture Collection, Rockville, MD. T hose 
with a "GM" prefix were obtained fro m The Human Genetic Mutant 
Cell Repository. Fibroblast line GM 1644 was derived from patient 
TS2BE. Fibroblast lines GM 1635 and GM 1643 were derived from 
patien t TS 1BE. GM 1635 grew from a biopsy of a shagreen patch, and 
G M 1643 grew from a biopsy of the patient's normal-appear ing skin. 
Culture conditions and colony- forming experiments: Fibroblasts 
wer e cultured and treated with MNNG after the method of Scudiero 
[18] and exactly as described in detai.l elsewhere [19] fo r fibroblast-
M NNG experimental series I-III. The fibroblast-MNNG experiments 
repor ted here were performed as pm·t of series II and III reported 
elsewhere [19], bu t the results for the TS lines were not reported 
t h e rewith [19]. Log-phase fibroblasts were treated with MNN G and 
t h e n cultured for 2 to 4 weeks. T he cells were then fixed, stained, and 
scor ed for colony formation. A colony consisted of an aggregate of 30 or 
more cells. T he colony-forming efficiency was defin ed as the number of 
colonies obta ined divided by the number of cells plated. Post-UV 
TA B L E I. Viability ratios of lymphobla.stoid lines on. the third day 
after irradiation with x -rays or UV 
Viabil ity ratio(+ SE)1' 
x-rays ( 100 rads) UV (6.0 J i m' ) 
Normal (n = 6) 0.58 ± 0.02 0.67 ± 0.03 
(range) (0.49-0.62) (0.59-0. 77) 
T S (n = 2) 0.34 ± 0.01 0.76 ± 0.04 
p = 0.0008 p = 0.17 
AT (n = 3) 0.22 ± 0.01 0.74 ± 0.02 
p < 0.0001 p = 0.19 
AT het (n = 2) 0.39 ± 0.03 0.72 ± O.Ql 
p = 0.0035 p = 0.48 
XP (n = 2) 0.60 ± 0.02 0.03 ± 0.01 
p = 0.55 p < 0.0001 
CS (n = 1) 0.63 0.23 
p < 0.001 
" n, number of lines in each group. 
b The mean ratio fo r each line was based on 3 to 7 experiments; 
results shown are averages of these means except for the CS line whose 
mean ratio is shown. P-value for compa1·ison wi th average of normal 
lines, except in '"'e ra~P Gf 1be viH: CS line whose mean ratio was 
co mpared to tl': ... ,·,Jtio of :•; !! l1 of 1 i1e normal lines. 
colony-forming abili ty (CFA) was calculated by dividing the colony-
forming efficiency of a line's cells treated at a given dose by the colony-
forming efficiency of the same line's w1treated cells in the same exper-
inlent. T he post-MNNG CFA cmve for each line was obtained by 
plotting the log of the percent remaining post-MNNG CFA as a 
function of MNNG dose. In each experiment with a cell line a straight 
line was fi t to the logm·ithms of the CFA values at the 6 p.M and higher 
doses using the method of least squares. From each straight line three 
CFA parameters were obtained by computer: the Do, Dot, and D10 
v!llues. The Do is the concentration of MNNG which reduced the CFA 
from any point on the exponential por tion of the curve to 37% of that 
point. The Dot and the D10 values m·e the concentrations of MNNG 
which reduce the CF A to 1% and 10%, respectively, of the colony-
forming efficiency of the untreated cells. For each of these CF A 
parameters the value repor ted for each cell line is computed from the 
line obtained by averaging the slopes and intercepts fro m the 2 to 7 
experiments performed on the cell line. Comparisons of CF A param-
eters among cell lines or between groups of cell lines were performed 
using ana lysis of variance methods [17], and 2-sided ?-values ar e 
reported. 
RESULTS 
Lymphoblastoid L ines 
F ig 1 sh ows t he m ean post-x-ray (100 rads) viability ratio of 
t h e 6 normal lin es and of t h e lines fro m t h e four neurocutaneous 
diseases. T h e post-x-ray viability of th e TS, AT, and AT het 
lines was s ignificantly less t ha n th at of th e normal lines. The 
post -x-ray viability of t h e XP a nd CS lines was in the normal 
range. Fig 2 sh ows dose r esp onse cm ves for t h e con trol lines 
a nd t h e TS a n d AT lines. T h e post-x-ray v iability ratios of the 
TS lines (O,e) was lower th a n t hat of th e nor mal lines at all 
d oses below 200 ra ds. T h e AT lines (.6,.6.) h ad lower ratio than 
t h e TS lines at all doses above 25 rads. 
T a ble I summarizes t h e postirradiation viability ratios of all 
t h e lines after irra dia tion wi th x-rays or UV. The TS, AT, a nd 
A T het lines wer e sign ifican tly m ore sens it ive t h a n normal to x-
rays but were not m or e sensit ive t h a n t h e normal lines to the 
U V r adiation . T h e XP and CS lines were not mor e sensitive 
t h an normal lines to x-rays b u t were significan tly hypersensitive 
to th e UV radiation . 
Fibroblast L ines 
The ranges of colony-forming efficiency of untreated lines 
(i.e., " plating efficiency") from all t he experimen ts were as 
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FIG 1. Viability of lymphoblastoid lines on the third day after irra-
diation with 100 rads of x- rays. e, mean viabili ty ratio of 4 to 7 
experiments; error bars denote ± 2 SEM. 
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TABLE II. Post-MNNG CFA p arameters of fibroblast lines from the 12 normal donors and the 2 TS patients" 
Experimental series II (Fig 3A) Experimental series 111 (fig 3/3) 
Donor 




3.9 11.8 20.9 3.4 10.4 18.4 









GM 1644 1.8 8.3 12.6 
" The Du, D ,0, and Do, values represent the f.LM concentration of MNNG present for 1 hr which reduces the CFA as fo llows: Du, from any J?Oint 
on the exponential portion of the CFA cu rve to 37% of that point; D 10 and D0 1, fro m, the untreated CFA to 10% and 1%, respectively, of that value. 
1
' The values shown are for the 7 and 5 normal lines identified in the legend of Fig 3A and 3B, respectively. 
,. This strain was grown from a biopsy of a shagreen patch. 
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FIG 2. Dose response curves for normal, TS, and AT lymphoblastoid 
lines. The shaded zone encompasses the post-x-ray viability curves of 
6 normal lines. Each symbol represents the mean viabili ty ratio of 2 to 
7 experiments; error bars denote ± 2 SEM. 
follow~: normal lines, 1-32%; GM 1635, 4-5%; GM 1643, 1-3%; 
GM 1644, 3-24%. Thus, the untreated T S lines had colony-
forming efficiencies within the range of those of the nor mal 
lines. Any differences in post-MNNG CFA between the T S and 
normal lines is, therefore, not due to differences between the 
untreated lines' colony-forming efficiencies. 
Fig 3A shows t he post-MNNG CFA curves of fibroblast lines 
from the 7 normal donors (shaded zone) and from the 2 TS 
patients of series II. The T S lines' post-MNNG CFA is well 
below t hat of the normal lines. The 7 normal lines of series II 
had average Do, D10, and D0 , values of 3.9, 11.8, and 20.9, 
respectively (Table II) . The Do, D 10, and Do, values of each of 
t he TS lines of series II (Table II) were significantly less (P < 
0.05) than the corresponding values of each of t he 7 normal 
lines [19]. The average Do, D 10, and Dot values of the 2 TS lines 
of series II were 1.7, 6.8, and 10.8, respectively . These T S values 
were significantly less (P< lO- a) than the corresponding values 
of the 7 normal lines. 
Fig 3B shows the post-MNNG CFA curves of the fibroblast 
lines obtained in series III from the 5 additional normal donors 
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FIG 3. Post-MNNG CFA of fibroblast lines from 12 normal donors 
and from TS patients TS1BE and TS2BE. The TS lines were studied 
in MNNG-experimental series II (A) and Ill (B) [19]. The shaded 
normal zones encompass the post-MNNG CFA curves of the normal 
fibroblasts which were stuclied concurrently with the TS lines. The 
nonexponential portion of the normal zone below the 6 f.LM dose of 
MNNG was fit by eye using the CFA values obtained at the 0.4, 2.0, 
and 4.0 f.LM doses. The exponential portion of the CFA curves of the 
normal lines (shown individually in reference 19) and of the TS lines 
was determined by averaging the slopes and intercepts calculated from 
the number (n) of experiments performed on each line as described in 
Materials and Methods. Each plotted point for the TS lines is the mean 
post-MNNG CFA of the number (n) of experiments performed on that 
line at the inclicated MNNG concentration. (A) normal lines: GM 9; 
GM 969; GM 1652; CRL 1187; CRL 1220; CRL 1221; CRL 1295. TS 
lines; e, GM 1643 (TSlBE), n=4; &, GM 1644 (TS2BE), n=5. (B) 
Normal lines: GM 2149; GM 2987; GM 3349; GM 3468; GM 3651. TS 
lines: e, GM 1635, n=4; &, GM 1643, n=1; both of these TS lines were 
from patient TS1BE, the former grown from a biopsy of a shagreen 
patch and the latter from a biopsy of normal-appearing skin. 
from patient TSlBE. All the experiments of Fig 3B were 
p erformed as coded experiments in which none of th e p ersonnel 
performing them knew the identity of the lines. The mean D o, 
D to, and Dot values for these 5 normal lines were 3.4, 10.4, and 
18.4, respectively (Table II) . The CFA cw·ve obtained in th e 
one experiment performed on the fibroblast line derived from 
the biopsy of the patient's normal-appearing skin (A., GM 1643) 
was practically identical to th e CF A curve obtained fTom the 4 
replicate experiments performed on the line derived from the 
biopsy of the patient's shagreen patch (e, GM 1635, Fig 3B; 
Table II) . The latter line's m ean Do, D w, and Dot values of 1.8, 
8.1, and 12.1, respectively (Table II) , were significantly less 
(P< 0.05) than the corresponding mean values of each of the 5 
normal lines with the exception of its D10 value which was not 
significantly less than that of strain GM 3651 (P= 0.16) . 
DISCUSSION 
Hypersensitivity to ionizing radiation has been found in cul-
tured cells from patients with the following primary nemonal 
degenerations: AT [ 4,5,16,20], Huntington disease [ 4,16,21], 
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Friedreich ataxia [22], olivopontocerebellar atrophy [23], and 
autonomic neurodegenerations of the inherited (familial dysau-
tonomia) [19,23] and sporadic (Shy-Drager syndrome) [19,24] 
types. The only patients with primary neuronal degenerations 
whose cells have been found not to be hypersensitive to ionizing 
radiation are XP20S (GM 2345) and XP17BE (GM 2253) (Fig 
1; T able I); their cells, however, are hypersensitive to UV 
radiation (Table 1). It is therefore apparent that all these 
primary neuronal degenerative diseases have in common a 
hypersensitivity to DNA-damaging agents. The hypersensitiv-
ity in these neurodegenerations is not limited to physical DNA-
damaging agents, however, for hypersensitivity to MNNG has 
been found in fibroblasts from patients with AT [ 4,18], Hunt-
ington disease [19], spinocerebellar ataxia [19], infant ile spinal 
muscular atrophy [19], and familial dysautonomia [19]. 
Hypersensitivity to ionizing radiation and to MNNG is pres-
ent in cells fro m patients with other neurological diseases with 
premature death of postmitotic excitable tissue: retinitis pig-
mentosa [25,26]; Usher syndl"Ome (congenital deafness and 
retinitis pigmentosa) [25,26]; myotonic muscular dystrophy 
[27,28]; and pseudohypertrophic muscular dystrophy (Duch-
enne and Becker types) [27,28]. Hypersensitivity to ionizing 
radiation has been reported also in several nonneurological 
diseases, viz., heredi tary retinoblastoma [29,30], D-deletion ret-
inoblastoma [29,30], partial trisomy of chromosome 13 [29], 
Fanconi anemia [9,29,30], progeria [29,30] and some cancer-
prone families [9,29,31]. In 2 of these diseases with hypersensi-
tivity to DNA-damaging agents there is reasonable evidence 
that the hypersensitivity results in clinical abnormalities: (1) in 
XP the freckles, skin atrophy, tumor formation, and acute sun 
sen sitivity appear to be caused by the UV radiation in sunligh t 
[3,13]; (2) some AT patients have suffered fatal acute radiosen-
sitivity reactions following therapeutic doses of ionizing radia-
tion [32-34]. 
W e have found hypersensitivity to ionizing radiation and to 
MNNG in the lymphoblastoid and fibroblast lines, respectively, 
derived from the 2 TS patients T S1BE and TS2BE. Colony-
forming ability of fibroblast lines GM 1635 and GM 1644, 
derived, respectively, from our 2 TS patients, has been studied 
by Paterson [ 4,9] who reported that line GM 1635 was hyper-
sen sitive to ionizing radiation but that line GM 1644 was not. 
The reason the fibroblast line for patient TS2BE was not found 
to be hypersensitive to ionizing radiation is not known. How-
ever, it is possible that our lymphoblast-x-ray and our fibro-
blast-MNNG tests are more sensitive tests than the fibroblast-
ionizing radiation test, as the following data. suggest: (1) in the 
aerobic fibroblast tests of Paterson [35] and .Al"lett [30] hyper-
sen sitivity to ionizing radiation was found in only one of a total 
of 5 AT het fibroblast lines, while in our studies [16] and those 
of Chen et al, [36] the lymphoblast-x-ray test detected hyper-
sen sitivity to ionizing radiation in a.lJ 13 AT het lymphocyte 
lines studied; (2) Arlett [21] and Paterson [ 4] found hypersen-
sitivity to ionizing radiation in some, but not a.ll , Huntington 
disease fibroblast lines, while the lymphoblast-x-ray test [16j, 
together with the fibroblast-MNNG test [19], have detected 
hypersensitivity in a.lJ 11 Huntington disease kindreds studied; 
(3) the Huntington disease fibroblast line GM 2173, which was 
not hypersensitive in the fibroblast test of Paterson [ 4], was 
hypersensitive in the fibroblast-MNNG test [19] , and the lym-
phoblastoid line GM 2172, derived from the same Huntington 
disease patient as was fibroblast line GM 2173, was one of the 
lymphoblastoid lines we found to be hypersensitive to x-rays 
[16]. 
While both AT and TS are neurocutaneous disorders, the 
major clinical and pathological manifestations of AT [ 4,5,8] a re 
markedly different from those of TS [11,37] with one relevant 
exception: in both diseases there is a marked nucleocytomegaly 
of various cell types [11,38-42]. Nucleocytomegaly occurs in 
vivo in cells of humans who have receivP.d therapeutic radiation 
[ 43,44] and is induced in mammalian cell s exposed in culture to 
ionizing radiation [ 45,46]. It is possible, therefore, that the 
nucleocytomegaly in cells from TS and AT patients results 
from inherited defects which render the cells abnorma.lly sen-
sit ive to ionizing radiation-type DNA damage. Such DNA dam-
age might result in vivo from endogenous chemicals and from 
"spontaneous" DNA damage [47], as has been suggested in the 
case of XP [3,13,16,48,49]. 
The hypersensitivity of TS cells to ionizing radiation may 
reflect, as is t hought to be the case in AT [ 4,5,8,50,51], an 
inherited defect in a mechanism normally involved in the repair 
of damaged DNA. It should be noted, however, that whether or 
not the hypersensitivity ofTS cells to ionizing radiation reflects 
defective DNA repair, the hypersensitivity holds the promise 
of being useful in in vitro diagnostic tests to distinguish TS cells 
from normal cells. For example, in kindreds where TS is inher-
ited in an autosomal dominant pattern [11], identification of 
the hypersensitivity in fetal t issues may serve to detect the 
presence of the TS gene and make possible prenatal diagnosis. 
Furthermore, in persons in whom TS is suspected but not fully 
documented clinica.lly [11], in vitro detection of hypersensitivity 
of their cells to ionizing radiation and/or to MNNG would be 
a useful diagnostic criterion. 
We thank Drs. Alan S. Rabson for helpful discussion a nd Gary L. 
Peck for providing the clinical information on the TS patients. 
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